Prevention of recurrent hemorrhage from a ruptured VADA is the primary goal of treatment (
13). The present study demonstrated that partial obliteration was significantly associated with a poor clinical outcome, and partial obliteration appears to be associated with high rates of recurrence. Specifically, remnant dissecting segments, left in place to preserve the antegrade flow of the perforating arteries, allow persistent flow through the unprotected false lumen, resulting in continuous flow to the fragile wall of the remnant pseudoaneurysm and serial enlargement or rupture (
14). In a previous report, involvement of the PICA was found to be the only independent risk factor for recurrence after endovascular treatment, and this risk factor was attributed to the unprotected remnant dissecting aneurysm adjacent to the PICA (
14). Furthermore, exact extension of the dissected segment in the parent artery cannot be assessed based on the existing endoluminal diagnostics. In effect, the initial dissection may extend to the orifice of the PICA or to the PICA itself. Stent-assisted coil embolization has been used frequently to preserve the patency of the parent and perforating vessels in the treatment of unruptured VADAs. However, due to the potential risk of coil compaction and remaining pathological potential in the vessel wall, this technique has been shown to be associated with incomplete obliteration and regrowth of residual aneurysms (
15-
17). Therefore, if a patient presents with residual aneurysmal filling on immediate postoperative angiography, short-term follow-up at 1 - 6 month intervals is recommended (
18). In our study, most patients who received SAC (71.4%) had partial obliteration and progressed to recurrent hemorrhage or serial enlargement of the residual dissecting aneurysm. Given the higher recurrence rate of ruptured VADA after incomplete obliteration and the risk of a fatal clinical outcome from recurrent hemorrhage, deconstructive techniques, such as internal trapping, are the preferred treatment modalities during the acute hemorrhagic phase.
Endovascular internal trapping is an effective technique for eliminating the potential risk of rebleeding and achieving long-term durable occlusion (
11,
19). Theoretically, ICT should be followed by concomitant occlusion of the parent and perforating vessels, which would result in cerebellar or brainstem infarctions. A recently published large cohort study demonstrated that occlusion of the PICA did not affect the likelihood of a favorable clinical outcome, despite being associated with an increased incidence of ischemic complications (
20). In the present study, ICT was adopted for the management of PICA-involved VADAs when sufficient collateral supplies from the contralateral PICA or the ipsilateral AICA were anticipated, and posttreatment infarction was not a significant predictor for long-term favorable clinical outcomes (P = 0.705). Therefore, we speculated that deliberate sacrifice of the PICA may be less harmful than previously expected. However, there are several limitations in applying ICT to all types of ruptured VADAs. First, sacrifice of the VA is not always possible, and alternative reconstructive therapy should be considered under specific conditions, such as when the patient has a dominant vertebral dissecting aneurysm with poor collaterals. Second, clinical outcomes after occlusion of major branches are unpredictable and can vary depending on the adequacy of an individual patient’s collateral circulation. There were no data concerning the perfusion of the sacrificed PICA in the aforementioned large-scale study, and PICA revascularization procedures are required for some patients who are at high risk for ischemic complications after undergoing deconstructive therapy. Moreover, several reports have demonstrated that medullary infarction is associated with poor clinical outcomes after treatment for ruptured VADAs (
13,
21). Given the fact that the segment of the VA distal to the PICA origin more frequently gives rise to perforating arteries than does the segment proximal to the PICA origin, internal trapping should be deliberately performed, even when treating a non-involved VADA with a location distal to the PICA.
Reconstructive treatment using stent-only therapy is beneficial for minimizing sacrifice of the parent and perforating vessels. Additionally, it is comparable to internal trapping for prevention of rebleeding of a ruptured VADA (
10,
22-
24). Consistent with many previous reports, we found promising results from stent-only therapy using multiple stents to treat ruptured VADAs with durable occlusion over a one-year follow-up period. With the advent of a neurovascular stent device, therapy with multiple overlapping stents is feasible and offers a high technical success rate. The addition of successive stent struts may effectively diminish shear stress in the aneurysm wall in proportion to the number of overlapping stents (
25,
26). However, reconstructive therapy, especially stent-only therapy, does not completely eliminate the rebleeding risk. Going forward, a prospective, multi-centered study of the therapeutic effects of multiple-stent therapy and its long-term validity is required.
The retrospective nature and the small sample size of this study are the main limitations to its ability to establish an optimal endovascular treatment strategy for this challenging disease entity. Specifically, a meaningful subgroup analysis between treatment modalities was not possible due to the limited number of cases. Given the fact that the initial WFNS grade was a significant variable influencing the clinical outcome, discrepancies in preoperative statuses may induce a selection bias and have an effect on the results. However, we speculated that a logistic regression analysis with a forward stepwise method could mitigate the effect of selection bias. There is a consensus in the literature that appropriately prescribed antiplatelet medication should be mandatory for all patients who have undergone stent placement (
24,
27). Therefore, an adequate postprocedural medication strategy should complement any endovascular treatment methods used.
Adequate angiographic analysis of ruptured VADAs should precede treatment, to allow for development of an optimized treatment strategy for individual patients. Given the relatively high recurrence rate of ruptured VADAs after incomplete obliteration and the association of a fatal clinical outcome from recurrent hemorrhage, prevention of rebleeding may outweigh the risk of parent and perforating artery occlusion. However, under specific conditions, reconstructive treatment using stent-only therapy could be an alternative with comparable therapeutic efficacy and long-term durability.